U.S. flag

An official website of the United States government

nsv6314596

  • Variant Calls:3
  • Validation:Not tested
  • Clinical Assertions: Yes
  • Region Size:1

Genome View

Select assembly:
Overlapping variant regions from other studies: 79 SVs from 17 studies. See in: genome view    
Remapped(Score: Perfect):137,249,696-137,249,696Question Mark
Overlapping variant regions from other studies: 79 SVs from 17 studies. See in: genome view    
Remapped(Score: Perfect):137,249,696-137,249,696Question Mark
Overlapping variant regions from other studies: 173 SVs from 29 studies. See in: genome view    
Remapped(Score: Perfect):140,515,210-140,515,210Question Mark
Overlapping variant regions from other studies: 173 SVs from 29 studies. See in: genome view    
Remapped(Score: Perfect):140,515,210-140,515,210Question Mark
Overlapping variant regions from other studies: 67 SVs from 16 studies. See in: genome view    
Remapped(Score: Perfect):72,499,360-72,499,360Question Mark
Overlapping variant regions from other studies: 72 SVs from 19 studies. See in: genome view    
Remapped(Score: Perfect):72,567,557-72,567,557Question Mark
Overlapping variant regions from other studies: 79 SVs from 17 studies. See in: genome view    
Submitted genomic137,570,833-137,570,833Question Mark
Overlapping variant regions from other studies: 79 SVs from 17 studies. See in: genome view    
Submitted genomic137,570,833-137,570,833Question Mark
Overlapping variant regions from other studies: 173 SVs from 29 studies. See in: genome view    
Submitted genomic140,836,347-140,836,347Question Mark
Overlapping variant regions from other studies: 173 SVs from 29 studies. See in: genome view    
Submitted genomic140,836,347-140,836,347Question Mark
Overlapping variant regions from other studies: 67 SVs from 16 studies. See in: genome view    
Submitted genomic72,791,701-72,791,701Question Mark
Overlapping variant regions from other studies: 72 SVs from 19 studies. See in: genome view    
Submitted genomic72,859,898-72,859,898Question Mark

Variant Region Placement Information

Variant Region IDPlacement TypeScoreAssemblyAssembly UnitReciprocitySequence IDChrStartStopstrand
nsv6314596RemappedPerfectGRCh38.p12Primary AssemblyFirst PassNC_000006.12Chr6137,249,696137,249,696+
nsv6314596RemappedPerfectGRCh38.p12Primary AssemblyFirst PassNC_000006.12Chr6137,249,696137,249,696+
nsv6314596RemappedPerfectGRCh38.p12Primary AssemblyFirst PassNC_000006.12Chr6140,515,210140,515,210+
nsv6314596RemappedPerfectGRCh38.p12Primary AssemblyFirst PassNC_000006.12Chr6140,515,210140,515,210+
nsv6314596RemappedPerfectGRCh38.p12Primary AssemblyFirst PassNC_000015.10Chr1572,499,36072,499,360+
nsv6314596RemappedPerfectGRCh38.p12Primary AssemblyFirst PassNC_000015.10Chr1572,567,55772,567,557+
nsv6314596Submitted genomicGRCh37 (hg19)Primary AssemblyNC_000006.11Chr6137,570,833137,570,833+
nsv6314596Submitted genomicGRCh37 (hg19)Primary AssemblyNC_000006.11Chr6137,570,833137,570,833+
nsv6314596Submitted genomicGRCh37 (hg19)Primary AssemblyNC_000006.11Chr6140,836,347140,836,347+
nsv6314596Submitted genomicGRCh37 (hg19)Primary AssemblyNC_000006.11Chr6140,836,347140,836,347+
nsv6314596Submitted genomicGRCh37 (hg19)Primary AssemblyNC_000015.9Chr1572,791,70172,791,701+
nsv6314596Submitted genomicGRCh37 (hg19)Primary AssemblyNC_000015.9Chr1572,859,89872,859,898+

Variant Call Information

Variant Call IDTypeMethodAnalysisSubject PhenotypeClinical InterpretationSource of InterpretationClinVar ID
nssv17976000interchromosomal translocationMultipleMultipleAbnormal facial shape; Abnormal facial shape; Anteverted nares; Anteverted nares; Cerebral calcification; Cerebral calcification; EPICANTHUS; Epicanthus; Epicanthus; Global developmental delay; Global developmental delay; Growth delay; Growth delay; Hyperactivity; Hyperactivity; Midface retrusion; Midface retrusion; Short palpebral fissure; Short palpebral fissure; Speech articulation difficulties; Speech articulation difficulties; TELECANTHUS; Telecanthus; Telecanthus; Thin upper lip vermilion; Thin upper lip vermilion; Wide nasal bridge; Wide nasal bridgeLikely pathogenicClinVarRCV000258773.2, VCV000267867.1
nssv17976004copy number lossMultipleMultipleAbnormal facial shape; Abnormal facial shape; Anteverted nares; Anteverted nares; Cerebral calcification; Cerebral calcification; EPICANTHUS; Epicanthus; Epicanthus; Global developmental delay; Global developmental delay; Growth delay; Growth delay; Hyperactivity; Hyperactivity; Midface retrusion; Midface retrusion; Short palpebral fissure; Short palpebral fissure; Speech articulation difficulties; Speech articulation difficulties; TELECANTHUS; Telecanthus; Telecanthus; Thin upper lip vermilion; Thin upper lip vermilion; Wide nasal bridge; Wide nasal bridgeLikely pathogenicClinVarRCV000258773.2, VCV000267867.1
nssv17976003interchromosomal translocationMultipleMultipleAbnormal facial shape; Abnormal facial shape; Anteverted nares; Anteverted nares; Cerebral calcification; Cerebral calcification; EPICANTHUS; Epicanthus; Epicanthus; Global developmental delay; Global developmental delay; Growth delay; Growth delay; Hyperactivity; Hyperactivity; Midface retrusion; Midface retrusion; Short palpebral fissure; Short palpebral fissure; Speech articulation difficulties; Speech articulation difficulties; TELECANTHUS; Telecanthus; Telecanthus; Thin upper lip vermilion; Thin upper lip vermilion; Wide nasal bridge; Wide nasal bridgeLikely pathogenicClinVarRCV000258773.2, VCV000267867.1

Variant Call Placement Information

Variant Call IDPlacement TypeScoreHGVSAssemblyReciprocitySequence IDChrStartStopstrand
nssv17976000RemappedPerfectGRCh38.p12First PassNC_000006.12Chr6137,249,696137,249,696+
nssv17976004RemappedPerfectNC_000006.12:g.137
249696delNC_000006
.12:g.140515210del
GRCh38.p12First PassNC_000006.12Chr6137,249,696137,249,696
nssv17976003RemappedPerfectGRCh38.p12First PassNC_000006.12Chr6140,515,210140,515,210+
nssv17976004RemappedPerfectNC_000006.12:g.137
249696delNC_000006
.12:g.140515210del
GRCh38.p12First PassNC_000006.12Chr6140,515,210140,515,210
nssv17976003RemappedPerfectGRCh38.p12First PassNC_000015.10Chr1572,499,36072,499,360+
nssv17976000RemappedPerfectGRCh38.p12First PassNC_000015.10Chr1572,567,55772,567,557+
nssv17976000Submitted genomicGRCh37 (hg19)NC_000006.11Chr6137,570,833137,570,833+
nssv17976004Submitted genomicNC_000006.11:g.137
570833delNC_000006
.11:g.140836347del
GRCh37 (hg19)NC_000006.11Chr6137,570,833137,570,833
nssv17976003Submitted genomicGRCh37 (hg19)NC_000006.11Chr6140,836,347140,836,347+
nssv17976004Submitted genomicNC_000006.11:g.137
570833delNC_000006
.11:g.140836347del
GRCh37 (hg19)NC_000006.11Chr6140,836,347140,836,347
nssv17976003Submitted genomicGRCh37 (hg19)NC_000015.9Chr1572,791,70172,791,701+
nssv17976000Submitted genomicGRCh37 (hg19)NC_000015.9Chr1572,859,89872,859,898+

No validation data were submitted for this variant

Clinical Assertions

Variant Call IDHGVSTypeAllele OriginSubject PhenotypeClinical InterpretationSource of InterpretationClinVar ID
nssv17976000interchromosomal translocationde novoAbnormal facial shape; Abnormal facial shape; Anteverted nares; Anteverted nares; Cerebral calcification; Cerebral calcification; EPICANTHUS; Epicanthus; Epicanthus; Global developmental delay; Global developmental delay; Growth delay; Growth delay; Hyperactivity; Hyperactivity; Midface retrusion; Midface retrusion; Short palpebral fissure; Short palpebral fissure; Speech articulation difficulties; Speech articulation difficulties; TELECANTHUS; Telecanthus; Telecanthus; Thin upper lip vermilion; Thin upper lip vermilion; Wide nasal bridge; Wide nasal bridgeLikely pathogenicClinVarRCV000258773.2, VCV000267867.1
nssv17976004GRCh37: NC_000006.11:g.137570833delNC_000006.11:g.140836347delcopy number lossde novoAbnormal facial shape; Abnormal facial shape; Anteverted nares; Anteverted nares; Cerebral calcification; Cerebral calcification; EPICANTHUS; Epicanthus; Epicanthus; Global developmental delay; Global developmental delay; Growth delay; Growth delay; Hyperactivity; Hyperactivity; Midface retrusion; Midface retrusion; Short palpebral fissure; Short palpebral fissure; Speech articulation difficulties; Speech articulation difficulties; TELECANTHUS; Telecanthus; Telecanthus; Thin upper lip vermilion; Thin upper lip vermilion; Wide nasal bridge; Wide nasal bridgeLikely pathogenicClinVarRCV000258773.2, VCV000267867.1
nssv17976003interchromosomal translocationde novoAbnormal facial shape; Abnormal facial shape; Anteverted nares; Anteverted nares; Cerebral calcification; Cerebral calcification; EPICANTHUS; Epicanthus; Epicanthus; Global developmental delay; Global developmental delay; Growth delay; Growth delay; Hyperactivity; Hyperactivity; Midface retrusion; Midface retrusion; Short palpebral fissure; Short palpebral fissure; Speech articulation difficulties; Speech articulation difficulties; TELECANTHUS; Telecanthus; Telecanthus; Thin upper lip vermilion; Thin upper lip vermilion; Wide nasal bridge; Wide nasal bridgeLikely pathogenicClinVarRCV000258773.2, VCV000267867.1

No genotype data were submitted for this variant

Support Center